Gender features of comorbidity in patients with coronary artery disease


Cite item

Full Text

Abstract

Aim. To study the factors associated with high levels of comorbidity in men and women with coronary artery disease (CAD). Materials and methods. The data analyzed 742 patients who were screened in the clinic of the research Institute CPSS in 2011, before planned operation coronary artery bypass grafting. All patients were divided into 2 groups: group I - men (n=595; 58 [54; 64] years), group II - women (n=147; 63 [57; 69] years). Results and discussion. The analysis showed that the presence of arterial hypertension and atrial fibrillation prevailed in the group of women (p<0.05), and postinfarction cardiosclerosis (PIC) in the group of men (p=0.004). Men mainly observed lighter I and II functional classes (FC) of angina (p=0.057 and p=0.007) and I stage of chronic heart failure (CHS; p<0.001), women, on the contrary, III and IV FC angina (p=0.005 and p=0.050) and stage III CHS (p<0.001). Atherosclerotic lesions of the arteries of the lower extremities (ALE) were significantly more common in men (p=0.022). Diabetes mellitus (DM), thyroid disease, varicose disease and bronchial asthma (BA) prevailed in the group of women (p<0.05), and chronic hepatitis (p=0.079) and urolithiasis in the group of men (p=0.028). Calculation of the level of comorbidity did not show significant intergroup differences (p>0.05). Although the average level of comorbid pathology prevailed in the whole population - 66% among women and 70.4% among men. Independent predictors that increase the level of comorbidity in male group were: the presence of underground experience, PIC in anamnesis, diabetes, chronic lung disease, stenosis of the ALE for more than 50% increase in the level of glucose in the group of women - the presence of the clinic of angina pectoris IV FC, PIC and movements in the history of the ALE stenosis more than 50%, diabetes, peptic ulcer disease, chronic lung disease, ASTHMA, improving glucose levels (p<0.05). Conclusion. According to the analysis, a high level of comorbidity was found in 13.6% of women and 11.6% of men. Factors associated with high levels of comorbidity, both in men and women were: the presence of diabetes, chronic lung disease, PIC, atherosclerosis of the ALE. At the same time only in women the high level of comorbidity was associated with angina IV FC, peptic ulcer disease, BA, and only in men - with the presence of underground experience. Detection of comorbid pathology in patients with IHD taking into account gender features is advisable for the implementation of patient-oriented approaches in daily clinical work.

About the authors

A N Sumin

Research Institute for Complex Issues of Cardiovascular Disease

Email: sumian@kemcardio.ru
д.м.н., зав. отд. мультифокального атеросклероза Kemerovo, Russia

E V Korok

Research Institute for Complex Issues of Cardiovascular Disease

к.м.н., н.с. лаб. патологии кровообращения отд. мультифокального атеросклероза Kemerovo, Russia

A V Shcheglova

Research Institute for Complex Issues of Cardiovascular Disease

к.м.н., н.с. лаб. патологии кровообращения отд. мультифокального атеросклероза Kemerovo, Russia

O L Barbarash

Research Institute for Complex Issues of Cardiovascular Disease

проф., член-корр. РАН, директор НИИ КПССЗ Kemerovo, Russia

References

  1. Pefoyo A.J, Bronskill S.E, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, Maxwell C.J, Bai Y, Wodchis W.P. The increasing burden and complexity of multimorbidity. BMC Pub Health. 2015;15:415. doi: 10.1186/s12889-015-1733-2.b
  2. Николаев Ю.А., Севостьянова Е.В., Митрофанов И.М., Поляков В.Я., Долгова Н.А. Особенности полиморбидности у пациентов терапевтической клиники кардиологического гастроэнтерологического профиля. Терапевтический архив. 2016;88(1):40-5 doi: 10.17116/terarkh20168140-45
  3. Бойцов С.А., Деев А.Д., Шальнова С.А. Смертность и факторы риска развития неинфекционных заболеваний в России: особенности, динамика, прогноз. Терапевтический архив. 2017;89(1):5-13 doi: 10.17116/terarkh20168140-45.
  4. Chamberlain A.M, St Sauver J.L, Gerber Y, Manemann S.M, Boyd C.M, Dunlay S.M, Rocca W.A, Finney Rutten L.J, Jiang R, Weston S.A, Roger V.L. Multimorbidity in heart failure: a community perspective. Am J Med. 2015;128(1):38-45. doi: 10.1016/j.amjmed.2014.08.024
  5. Rocca W.A, Boyd C.M, Grossardt B.R, Bobo W.V, Finney Rutten L.J, Roger V.L, Ebbert J.O, Therneau T.M, Yawn B.P, St Sauver J.L. Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc. 2014;89(10):1336-49. doi: 10.1016/j.mayocp.2014.07.010
  6. Зыков М.В. Особенности течения и стратификации риска осложнений острого коронарного синдрома в сочетании с почечной дисфункцией и различной стратегией лечения (обзор литературы). Комплексные проблемы сердечно - сосудистых заболеваний. 2015;(3):68-78
  7. Насонов Е.А., Попкова Т.В., Новикова Д.С. Сердечно - сосудистая патология при ревматических заболеваниях. Терапевтический архив. 2016;88(5):4-12 doi: 10.17116/terarkh20168140-45
  8. Юсупова А.О., Кожевникова М.В., Беленков Ю.Н., Привалова Е.В. Коморбидная патология: ишемическая болезнь сердца и гастроэзофагеальная рефлюксная болезнь. Клиническая медицина. 2017;95(4):293-301 doi: 10.18821/0023-2149-2017-95-4-291-301
  9. Violán C, Foguet-Boreu Q, Roso-Llorach A, Rodriguez-Blanco T, Pons-Vigués M, Pujol-Ribera E, Muñoz-Pérez M.Á, Valderas J.M. Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross - sectional study. BMC Pub Health. 2014;14:530. doi: 10.1186/1471-2458-14-530
  10. Charlson M.E, Pompei P, Ales K.L, Mac Kenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373-83. doi: 10.1016/ 0021-9681(87)90171-8
  11. St Sauver J.L, Boyd C.M, Grossardt B.R, Bobo W.V, Finney Rutten L.J, Roger V.L, Ebbert J.O, Therneau T.M, Yawn B.P, Rocca W.A. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open. 2015;5(2):e006413. doi: 10.1136/bmjopen-2014-006413
  12. Rizza A, Kaplan V, Senn O, Rosemann T, Bhend H, Tandjung R; FIRE study group. Age - and gender -related prevalence of multimorbidity in primary care: the Swiss FIRE project. BMC Fam Pract. 2012;13:113. doi: 10.1186/1471-2296-13-113
  13. Van Oostrom S.H, Gijsen R, Stirbu I, Korevaar J.C, Schellevis F.G, Picavet H.S, Hoeymans N. Time Trends in Prevalence of Chronic Diseases and Multimorbidity Not Only due to Aging: Data from General Practices and Health Surveys. PLoS One. 2016;11(8):e0160264. doi: 10.1371/journal.pone.0160264. eCollection 2016.
  14. Holzer B.M, Siebenhuener K, Bopp M, Minder C.E. Evidence - based design recommendations for prevalence studies on multimorbidity: improving comparability of estimates. Popul Health Metr. 2017;15(1):9. doi: 10.1186/s12963-017-0126-4
  15. Шальнова С.А., Оганов Р.Г., Деев А.Д., Имаева А.Э., Лукьянов М.М., Артамонова Г.В., Гатагонова Т.М., Гринштейн Ю.И., Дупляков Д.В., Ефанов А.Ю., Жернакова Ю.В., Ильин В.А., Либис Р.А., Минаков А.В., Невзорова В.А., Недогода С.В., Романчук С.В., Ротарь О.П., Трубачева И.А., Шляхто Е.В. и др. Сочетания ишемической болезни сердца с другими неинфекционными заболеваниями в популяции взрослого населения: ассоциации с возрастом и факторами риска. Кардиоваскулярная терапия и профилактика. 2015;(4):44-51
  16. Бойцов С.А., Лукьянов М.М., Якушин С.С., Марцевич С.Ю., Воробьев А.Н., Загребельный А.В., Переверзева К.Г., Правкина Е.А., Деев А.Д., Андреенко Е.Ю., Ершова А.И., Мешков А.Н., Мясников Р.П., Сердюк С.С., Харлап М.С., Базаева Е.В., Козьминский А.Н., Мосейчук К.А., Кудряшов Е.Н. Регистр кардиоваскулярных заболеваний (рекваза): диагностика, сочетанная сердечно - сосудистая патология, сопутствующие заболевания и лечение в условиях реальной амбулаторнополиклинической практики. Кардиоваскулярная терапия и профилактика. 2014;(6):44-50
  17. Agur K, Mc Lean G, Hunt K, Guthrie B, Mercer S.W. How Does Sex Influence Multimorbidity? Secondary Analysis of a Large Nationally Representative Dataset. Int J Envir Res Pub Health. 2016;13(4):391. doi: 10.3390/ijerph13040391
  18. Шляхто Е.В., Конради А.О. Основные направления и перспективы трансляционных исследований в кардиологии. Вестник Росздравнадзора. 2015;(5):33-7
  19. Chung J.S, Young H.N, Moreno M.A, Kliems H, Cox E.D. Patient - centred outcomes research: brave new world meets old institutional policies. Fam Pract. 2017;34(3):296-300. doi: 10.1093/fampra/cmw129
  20. Bouchard C, Antunes-Correa L.M, Ashley E.A, Franklin N, Hwang P.M, Mattsson C.M, Negrao C.E, Phillips S.A, Sarzynski M.A, Wang P.Y, Wheeler M.T. Personalized preventive medicine: genetics and the response to regular exercise in preventive interventions. Prog Cardiovasc Dis. 2015;57(4):337-46. doi: 10.1016/j.pcad.2014.08.005

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies